MedTech Innovators
The NIH MedTech Grant is one of the most prestigious U.S. funding opportunities for companies developing innovative biomedical technologies, offering up to $306,872 in Phase I and over $2 million in Phase II. It supports early-stage R&D, technical validation, and the development of market-ready medical solutions. With strict eligibility criteria and a competitive review process, securing this grant requires strategy, precision, and experience. If your company is considering applying, reach out to us – we can guide you through the entire process and maximize your chances of winning the funding.
How much there is to gain?
Phase I
Feasibility / prototyping
total costs
Phase II
full R&D/verification,
early clinical where appropriate
total costs
For whom?
Must be a U.S. company
For-Profit U.S. Small Business Concerns (SBCs)
Must be primarily owned and controlled by U.S. citizens
Company Size: Must have 500 or fewer employees including affiliates
For what?
Projects focusing on medical technology related to SBIRT (Screening, Brief Intervention, and Referral to Treatment)
Funding supports the development of products/services that align with the mission of participating NIH Institutes and Centers (ICs)
Grants are for R&D that bridges the gap between basic research and market-ready products
Eligibility requirements
The NIH SBIR program focuses heavily on the company’s structure and the Principal Investigator’s role.
Structure
Be a for-profit business entity
(e.g., corporation, LLC)
Territory
Be located in and conduct all
R&D in the United States
Employee count
Employee count: Including affiliates, the company must have no more than 500 employees
Ownership
Ownership: Be more than 50% directly owned and controlled by U.S. citizens or permanent resident aliens (or meet specific requirements for VC-owned concerns)
Key Personnel (PI/PD)
Key Personnel (PI/PD): The Principal Investigator / Project Director must have their primary employment (more than 50% of their time/effort) with the small business at the time of the award and throughout the project period